The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: 2.75 (15.49%)
Spread: 1.00 (5.00%)
Open: 18.50
High: 23.50
Low: 18.50
Prev. Close: 17.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Wed, 23rd Jun 2021 16:09

Thursday 24 June 
Argo Blockchain PLCAGM
Atalaya Mining PLCAGM
Boston International Holdings PLCGM
Fresnillo PLCAGM
Gemfields Group LtdAGM
Incanthera PLCAGM
Itaconix PLCAGM
Kavango Resources PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Science in Sport PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
STM Group PLCAGM
Tandem Group PLCAGM
THG PLCAGM
Westminster Group PLCAGM
Friday 25 June 
Cadogan Petroleum PLCAGM
Entain PLCAGM
Gulf Marine Services PLCGM re share placing
HeiQ PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Inspiration Healthcare Group PLCAGM
Norman Broadbent PLCAGM
SDX Energy PLCAGM
Serabi Gold PLCAGM
Tesco PLCAGM
Tiziana Life Sciences PLCAGM
Monday 28 June 
Anglo-Eastern Plantations PLCAGM
Avacta Group PLCAGM
City Pub Group PLCAGM
Escape Hunt PLCAGM
Eurasia Mining PLCAGM
Futura Medical PLCAGM
Gulf Marine Services PLCAGM
Hiscox LtdEGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
ImmuPharma PLCAGM
Kanabo Group PLCAGM
Longboat Energy PLCGM re reverse takeover
Pennon Group PLCGM re share consolidation & changes to AoA
Symphony Environment Technologies PLCAGM
Volvere PLCAGM
Zinnwald Lithium PLCAGM
Tuesday 29 June 
Anglo Asian Mining PLCAGM
Attraqt Group PLCAGM
British & American Investment Trust PLCAGM
City of London Investment Group PLCGM re appropriation of distributable reserves of certain historic dividends
Cizzle Biotechnology Holdings PLCAGM
Crimson Tide PLCAGM
Gama Aviation PLCAGM
GB Group PLCAGM
Greencare Capital PLCAGM
Impellam Group PLCAGM
Mears Group PLCAGM
Mobile Tornado Group PLCAGM
MyHealthChecked PLCAGM
NAHL Group PLCAGM
Pacific Assets Trust PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
Sportech PLCAGM
Sportech PLCGM re move to AIM from London Main Market
St Mark Homes PLCAGM
Universe Group PLCAGM
Watchstone Group PLCAGM
Wednesday 30 June 
4Basebio UK Societas PLCAGM
Afentra PLCAGM
Angle PLCAGM
ASA International Group PLCAGM
Asiamet Resources LtdAGM
Bacanora Lithium PLCAGM
Block Energy PLCAGM
Chesterfield Resources PLCAGM
Cobra Resources PLCAGM
Creo Medical Group PLCAGM
DeepMatter Group PLCAGM
Eden Research PLCAGM
Gamesys Group PLCGM re Premier Entertainment acquire shares
Getech Group PLCAGM
Good Energy Group PLCAGM
Gulf Marine Services PLCAGM
Immotion Group PLCAGM
Ingenta PLCAGM
Inspired Energy PLCAGM
Integrated Diagnostics Holdings PLCAGM
Kefi Gold & Copper PLCAGM
Kingfisher PLCAGM
Kropz PLCAGM
London Security PLCAGM
Longboat Energy PLCAGM
Lookers PLCAGM
Metals Exploration PLCAGM
Midatech Pharma PLCAGM
National World PLCAGM
Pathfinder Minerals PLCAGM
Petropavlovsk PLCAGM
Phoenix Global Resources PLCAGM
Plaza Centers NVAGM
Provident Financial PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
SpaceandPeople PLCAGM
Tower Resources PLCAGM
TP Group PLCAGM
Victoria Oil & Gas PLCAGM
W Resources PLCAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 May 2024 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling some hawkish Federal Reserve interest rate expectations.

Read more
3 May 2024 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.